Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen shares could rise 20% on robust drug pipeline, Barron's contends
Biogen shares could rise 20% on robust drug pipeline, Barron's contends
Biogen shares could rise 20% on robust drug pipeline, Barron's contends
Submitted by
admin
on May 23, 2014 - 6:58am
Source:
The Fly on the Wall
News Tags:
Biogen Idec
Tysabri
Avonex
Tecfidera
Eloctate
Alprolix
Headline:
Biogen shares could rise 20% on robust drug pipeline, Barron's contends
Do Not Allow Advertisers to Use My Personal information
